Empatica Funding: How Much Did They Raise & Key Investors

How Much Did Empatica Raise?
Funding & Key Investors

Empatica, a prominent player in the healthcare technology sector, has secured significant enterprise-level funding, with its total capital raised standing at $7.8M. The company recently announced an undisclosed amount in its latest funding round, underscoring continued investor confidence in its innovative approach to digital health and medical devices. This latest infusion of capital follows a series of strategic investments that have propelled Empatica's growth and development in the competitive health tech landscape.

What is Empatica?

Empatica

Manufacturing

Medical Devices & Equipment

Healthcare Software

Empatica operates at the critical intersection of digital health, artificial intelligence, and medical device innovation. The company specializes in developing medical-grade wearable devices and sophisticated digital health platforms engineered to meticulously monitor physiological signals. These technologies provide continuous, real-world insights into human health, enabling clinicians, researchers, and pharmaceutical companies to gather and analyze vital health data from patients outside conventional clinical settings. Empatica's solutions are instrumental in monitoring neurological conditions, tracking subtle physiological changes, and bolstering clinical research through advanced digital biomarkers and robust remote patient monitoring systems. Originally a spin-off from the MIT Media Lab, Empatica was founded by a team of researchers and engineers dedicated to addressing healthcare challenges with cutting-edge wearable sensor technology and machine learning.

How much funding has Empatica raised?

Empatica has raised a total of $7.8M across 3 funding rounds:

2014

Angel/Seed

$2M

2015

Angel/Seed

$782K

2017

Series A

$5M

Angel/Seed (2014): $2M, investors not publicly disclosed

Angel/Seed (2015): $782K, investors not publicly disclosed

Series A (2017): $5M, investors not publicly disclosed

What's next for Empatica?

With its recent enterprise-level funding, Empatica is strategically positioned to accelerate its product development pipeline and expand its market reach. The company's focus on continuous physiological monitoring and AI-driven insights aligns with the growing demand for personalized and preventative healthcare solutions. Future initiatives are likely to involve enhancing the capabilities of its medical wearables, further refining its data analytics platforms, and forging new partnerships within the healthcare ecosystem. This sustained investment will empower Empatica to solidify its leadership in remote patient monitoring and digital biomarkers, driving innovation in how chronic conditions are managed and clinical trials are conducted.

See full Empatica company page

See More Financial Insights